191 related articles for article (PubMed ID: 22902677)
1. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR
Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.
Wu X; Lipinski T; Carrel FR; Bailey JJ; Bundle DR
Org Biomol Chem; 2007 Nov; 5(21):3477-85. PubMed ID: 17943207
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and immunogenicity of a glycopolymer conjugate.
Lipinski T; Kitov PI; Szpacenko A; Paszkiewicz E; Bundle DR
Bioconjug Chem; 2011 Feb; 22(2):274-81. PubMed ID: 21186827
[TBL] [Abstract][Full Text] [Related]
4. Model alpha-mannoside conjugates: immunogenicity and induction of candidacidal activity.
Paulovicová L; Bystrický S; Paulovicová E; Karelin AA; Tsvetkov YE; Nifantiev NE
FEMS Immunol Med Microbiol; 2010 Apr; 58(3):307-13. PubMed ID: 20113351
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate.
Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
Int Immunopharmacol; 2012 Oct; 14(2):179-87. PubMed ID: 22835427
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
Han Y; Rhew KY
Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
[TBL] [Abstract][Full Text] [Related]
7. Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.
Bundle DR; Nycholat C; Costello C; Rennie R; Lipinski T
ACS Chem Biol; 2012 Oct; 7(10):1754-63. PubMed ID: 22877569
[TBL] [Abstract][Full Text] [Related]
8. Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.
Xin H; Cartmell J; Bailey JJ; Dziadek S; Bundle DR; Cutler JE
PLoS One; 2012; 7(4):e35106. PubMed ID: 22563378
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with mannan protects mice against systemic aspergillosis.
Liu M; Machová E; Neščáková Z; Medovarská I; Clemons KV; Martinez M; Chen V; Bystrický S; Stevens DA
Med Mycol; 2012 Nov; 50(8):818-28. PubMed ID: 22587733
[TBL] [Abstract][Full Text] [Related]
10. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
Han Y; Ulrich MA; Cutler JE
J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan.
Lipinski T; Fitieh A; St Pierre J; Ostergaard HL; Bundle DR; Touret N
J Immunol; 2013 Apr; 190(8):4116-28. PubMed ID: 23514738
[TBL] [Abstract][Full Text] [Related]
12. Candida albicans mannan-protein conjugate as vaccine candidate.
Bystrický S; Paulovicová E; Machová E
Immunol Lett; 2003 Feb; 85(3):251-5. PubMed ID: 12663139
[TBL] [Abstract][Full Text] [Related]
13. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
Xin H; Cutler JE
Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunogenicity of polysaccharide-protein conjugate composed of galactoglucoxylomannan of Cryptococcus laurentii.
Bystrický S; Paulovicová E; Machová E
FEMS Microbiol Lett; 2004 Jun; 235(2):311-4. PubMed ID: 15183879
[TBL] [Abstract][Full Text] [Related]
15. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
Han Y; Rhew KY
Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
[TBL] [Abstract][Full Text] [Related]
17. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.
Pietrella D; Rachini A; Torosantucci A; Chiani P; Brown AJ; Bistoni F; Costantino P; Mosci P; d'Enfert C; Rappuoli R; Cassone A; Vecchiarelli A
Vaccine; 2010 Feb; 28(7):1717-25. PubMed ID: 20038431
[TBL] [Abstract][Full Text] [Related]
18. Immune responsiveness of a novel peptidoglycan conjugate prepared from surface Candida immunogens: mannan and CR3-related protein.
Paulovicová E; Bystrický S; Machová E; Bujdáková H
FEMS Immunol Med Microbiol; 2008 Aug; 53(3):421-8. PubMed ID: 18625018
[TBL] [Abstract][Full Text] [Related]
19. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
Schmidt CS; White CJ; Ibrahim AS; Filler SG; Fu Y; Yeaman MR; Edwards JE; Hennessey JP
Vaccine; 2012 Dec; 30(52):7594-600. PubMed ID: 23099329
[TBL] [Abstract][Full Text] [Related]
20. Candida albicans cell wall antigens for serological diagnosis of candidemia.
Kondori N; Edebo L; Mattsby-Baltzer I
Med Mycol; 2003 Feb; 41(1):21-30. PubMed ID: 12627801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
